255 related articles for article (PubMed ID: 19459418)
1. [Effects of beta 1-adrenoblocker bisoprolol on endothelial dysfunction in patients with stable angina pectoris in combination with chronic obstructive pulmonary disease].
Grigor'eva NIu; Sharabrin EG; Kuznetsov AN; Mazalov KV; Kontorshchikova KN; Koroleva EF
Ter Arkh; 2009; 81(3):28-31. PubMed ID: 19459418
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of a cardioselective beta1-adrenoblocker bisoprolol in patients with chronic obstructive pulmonary disease in combination with ischemic heart disease].
Tsvetkova OA; Veselovskaia MV
Ter Arkh; 2007; 79(3):25-9. PubMed ID: 17526191
[TBL] [Abstract][Full Text] [Related]
3. Long-term treatment of angina pectoris with bisoprolol or atenolol in patients with chronic obstructive bronchitis: a randomized, double-blind crossover study.
Dorow P; Thalhofer S; Bethge H; Disselhoff G; Wagner G
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S36-44. PubMed ID: 11527135
[TBL] [Abstract][Full Text] [Related]
4. Bisoprolol in the treatment of chronic stable angina pectoris.
Terol I; Plaza L; Rodrigo F
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S208-12. PubMed ID: 11527131
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamics and exercise tolerance after bisoprolol, nifedipine, and their combination in patients with angina pectoris.
Schnellbacher K; Bestehorn HP; Roskamm H
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S201-7. PubMed ID: 11527130
[TBL] [Abstract][Full Text] [Related]
6. Bisoprolol alone and in combination with amlodipine or nifedipine in the treatment of chronic stable angina.
Ferguson JD; Ormerod O; Lenox-Smith AJ
Int J Clin Pract; 2000; 54(6):360-3. PubMed ID: 11092108
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy and safety of different beta-blockers in patients with isolated systolic hypertension associated with diabetes mellitus and obstructive pulmonary diseases].
Kukes VG; Ostroumova OD; Mamaev VI; Batutina AM; Abakumov IuE; Zykova AA
Ter Arkh; 2003; 75(8):43-7. PubMed ID: 14520850
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of therapy with bisoprolol and ivabradine in patients with ischemic heart disease combined with chronic obstructive pulmonary disease assessment of parameters of 24-hour ECG monitoring].
Grigor'eva NIu
Kardiologiia; 2009; 49(7-8):38-41. PubMed ID: 19656105
[TBL] [Abstract][Full Text] [Related]
9. [Endothelial dysfunction in patients with combined coronary heart disease and chronic obstructive pulmonary disease].
Grigor'eva NIu; Sharabrin EG; Kontorshchikova KN; Kuznetsov AN; Mazalov KV; Koroleva EF
Klin Med (Mosk); 2009; 87(8):41-4. PubMed ID: 19827529
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of beta-blockers in the treatment of stable angina pectoris.
de Muinck ED; Lie KI
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S123-8. PubMed ID: 11527115
[TBL] [Abstract][Full Text] [Related]
11. [A new beta 1-receptor blocker in the therapy of essential hypertension and angina pectoris].
Burkart F; Stamm G; Witassek F
Schweiz Med Wochenschr; 1989 May; 119(18):575-81. PubMed ID: 2568685
[TBL] [Abstract][Full Text] [Related]
12. Bisoprolol in patients with heart failure and moderate to severe chronic obstructive pulmonary disease: a randomized controlled trial.
Hawkins NM; MacDonald MR; Petrie MC; Chalmers GW; Carter R; Dunn FG; McMurray JJ
Eur J Heart Fail; 2009 Jul; 11(7):684-90. PubMed ID: 19460848
[TBL] [Abstract][Full Text] [Related]
13. [Clinicofunctional characteristics of the heart in patients with stable angina pectoris in combination with chronic obstructive pulmonary disease].
Borovkov NN; Grigor'eva NIu
Ter Arkh; 2006; 78(12):24-7. PubMed ID: 17294859
[TBL] [Abstract][Full Text] [Related]
14. [The efficacy and safety of the combination of β-blocker bisoprolol and if inhibitor I(f) ivabradine in patients with stable angina and chronic obstructive pulmonary disease].
Ageev FT; Makarova GV; Patrusheva IF; Orlova IaA
Kardiologiia; 2010; 50(10):22-6. PubMed ID: 21118175
[TBL] [Abstract][Full Text] [Related]
15. Inadequate control of heart rate in patients with stable angina: results from the European heart survey.
Daly CA; Clemens F; Sendon JL; Tavazzi L; Boersma E; Danchin N; Delahaye F; Gitt A; Julian D; Mulcahy D; Ruzyllo W; Thygesen K; Verheugt F; Fox KM;
Postgrad Med J; 2010 Apr; 86(1014):212-7. PubMed ID: 20354044
[TBL] [Abstract][Full Text] [Related]
16. Ivabradine versus bisoprolol.
Fazio G; Sarulo F; Licata P; D'Angelo L; Passantino S; Visconti C; Zarcone P; Spanò C; Novo G; Novo S
Minerva Cardioangiol; 2010 Apr; 58(2):281-2. PubMed ID: 20440257
[No Abstract] [Full Text] [Related]
17. [What is the danger of long-term application of beta blockers in patients with ischemic heart disease and concomitant chronic obstructive pulmonary disease?].
Kozlova LI; Aĭsanov ZR; Chuchalin AG
Ter Arkh; 2005; 77(3):18-23. PubMed ID: 15881093
[TBL] [Abstract][Full Text] [Related]
18. Bisoprolol improved endothelial function and myocardium survival of hypertension with stable angina: a randomized double-blinded trial.
Lin ZP; Dong M; Liu J
Eur Rev Med Pharmacol Sci; 2013 Mar; 17(6):794-801. PubMed ID: 23609363
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary effects of acebutolol, a "cardioselective" beta adrenergic blocking agent.
DiBianco R; Dickie KJ; Singh S; Katz RJ; Costello RB; Gottdiene JS; Laddu AR; Fletcher RD
Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):1-7. PubMed ID: 6120142
[TBL] [Abstract][Full Text] [Related]
20. [Cardioselective beta-adrenoblockers in patients with stable angina pectoris. Comparison of efficacy and safety].
Dupliakov DV; Glukhova VL; Vozhdaeva ZI; Golovina GA
Ter Arkh; 2006; 78(9):43-8. PubMed ID: 17076224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
